| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |